PQ 240
240. Deputy Ken O'Flynn asked the Minister for Health the average and median time taken for reimbursement decisions for orphan or rare disease medicines over the past five years; the specific timelines applicable in the case of treatments for Friedreich’s ataxia; and whether any delays have arisen in the assessment process for this category of medicines. [29079/26]
Introduced
22 April 2026
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
22 April 2026
Summary
240. Deputy Ken O'Flynn asked the Minister for Health the average and median time taken for reimbursement decisions for orphan or rare disease medicines over the past five years; the specific timelines applicable in the case of treatments for Friedreich’s ataxia; and whether any delays have arisen in the assessment process for this category of medicines. [29079/26]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 22 April 2026
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2026-04-22/240/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2026-04-22/pq_240